Showing results (31-40 of 240) with videos related to

Sort By:
Pageof 24
Current Opinion in Chemical Biology|March 9, 2020
Proteolysis targeting chimeras (PROTACs) for epigenetics researchAnja Vogelmann, Dina Robaa, Wolfgang Sippl, et al.
Anticancer Research|May 30, 2008
Biphenylalkylacetylhydroquinone ethers suppress the proliferation of murine B16 melanoma cellsNicolle Fernandes, Manfred Jung, Ali Daoud, et al.
Organic & Biomolecular Chemistry|May 17, 2023
Total synthesis and biological evaluation of histone deacetylase inhibitor WF-3161Michael Kohr, Niklas Papenkordt, Manfred Jung, et al.
Chemical Communications (Cambridge, England)|February 1, 2023
Photoreductive β-aminoalkylation with amino acids affords functionalized γ-aminoketones for nucleoside mimicsSebastian O Klein, Adina A Baniahmad, Manfred Jung
ACS Pharmacology & Translational Science|February 21, 2022
Comparison of Cellular Target Engagement Methods for the Tubulin Deacetylases Sirt2 and HDAC6: NanoBRET, CETSA, Tubulin Acetylation, and PROTACsAnja Vogelmann, Manfred Jung, Finn K Hansen, et al.
Anticancer Research|August 15, 2002
Comparative action of cobalt carbonyl complexes on cancer cells using human tumor xenograftsThomas Roth, Chris Eckert, Heinz-Herbert Fiebig, et al.
Clinical Epigenetics|January 25, 2011
Histone deacetylase (HDAC) inhibitors in recent clinical trials for cancer therapyJulia M Wagner, Björn Hackanson, Michael Lübbert, et al.
Future Medicinal Chemistry|November 20, 2012
Current trends in epigenetic drug discoveryDiana A Stolfa, Oliver Einsle, Wolfgang Sippl, et al.
Archiv Der Pharmazie|January 12, 2012
Small molecule inhibitors of histone acetyltransferases as epigenetic tools and drug candidatesSilviya D Furdas, Srinivasaraghavan Kannan, Wolfgang Sippl, et al.
The Journal of Biological Chemistry|February 3, 2005
Substrate-specific activation of sirtuins by resveratrolMatt Kaeberlein, Thomas McDonagh, Birgit Heltweg, et al.
Pageof 24